Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

A phase II trial of docetaxel and erlotinib as first-line therapy for elderly patients with androgen-independent prostate cancer

  • Mitchell Gross1Email author,
  • Celestia Higano2,
  • Allan Pantuck3,
  • Olga Castellanos1,
  • Erica Green1,
  • Koo Nguyen1 and
  • David B Agus1
BMC Cancer20077:142

DOI: 10.1186/1471-2407-7-142

Received: 08 March 2007

Accepted: 27 July 2007

Published: 27 July 2007

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
8 Mar 2007 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
13 Apr 2007 Reviewed Reviewer Report - Jonathan Rosenberg
12 Jun 2007 Reviewed Reviewer Report - William Berry
15 Jun 2007 Reviewed Reviewer Report - Damian Laber
28 Jun 2007 Author responded Author comments - Mitchell Gross
Resubmission - Version 3
28 Jun 2007 Submitted Manuscript version 3
12 Jul 2007 Reviewed Reviewer Report - Jonathan Rosenberg
12 Jul 2007 Reviewed Reviewer Report - Damian Laber
24 Jul 2007 Author responded Author comments - Mitchell Gross
Resubmission - Version 4
24 Jul 2007 Submitted Manuscript version 4
Publishing
27 Jul 2007 Editorially accepted
27 Jul 2007 Article published 10.1186/1471-2407-7-142

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Louis Warschaw Prostate Cancer Center, Cedars-Sinai Medical Center
(2)
Department of Medicine, University of Washington, Seattle Cancer Care Alliance
(3)
Department of Urology, David Geffen School of Medicine at UCLA

Advertisement